Dengyun Zhao
Zhengzhou, 450000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Targeting SRSF6 to Enhance Cisplatin Sensitivity by Modulating Redox Balance via NFE2L1 exon 4 Splicing in ESCC.
Journal: International journal of biological sciences
Published: January 16, 2026
The emerging roles of alternative splicing in modulating tumor immune responses and immunotherapies.
The emerging roles of alternative splicing in modulating tumor immune responses and immunotherapies.
Journal: Cell death and differentiation
Published: November 17, 2025
RTN4IP1 Contributes to ESCC via Regulation of Amino Acid Transporters.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 05, 2024
CHI-KAT8i5 suppresses ESCC tumor growth by inhibiting KAT8-mediated c-Myc stability.
Journal: Cell reports
Published: April 25, 2024
Ribonucleotide reductase small subunit M2 promotes the proliferation of esophageal squamous cell carcinoma cells via HuR-mediated mRNA stabilization.
Journal: Acta pharmaceutica Sinica. B
Published: April 23, 2024
Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growth.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 12, 2023
Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2.
Journal: Signal transduction and targeted therapy
Published: April 27, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026